Huynh Thanh N, Weigt S Sam, Belperio John A, Territo Mary, Keane Michael P
Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1690, USA.
J Transplant. 2009;2009:917294. doi: 10.1155/2009/917294. Epub 2009 Sep 15.
The prognosis of patients with hematopoietic stem cell transplants (HSCTs) who require admission to the intensive care unit (ICU) has been regarded as extremely poor. We sought to re-evaluate recent outcomes and predictive factors in a retrospective cohort study. Among the 605 adult patients that received an HSCT between 2001 and 2006, 154 required admission to the ICU. Of these, 47% were discharged from the ICU, 36% were discharged from the hospital, and 19% survived 6 months. Allogeneic transplant, mechanical ventilation, vasopressor-use, and neutropenia were each associated with increased mortality, and the mortality of patients with all four characteristics was 100%. Hemodialysis was also associated with increased mortality in a Kaplan-Meier analysis but did not appear important in a multivariate tree analysis. A final Cox model confirmed that allogeneic transplant, mechanical ventilation, and vasopressor-use were each independent risk factors for mortality in the 6 months following ICU admission.
需要入住重症监护病房(ICU)的造血干细胞移植(HSCT)患者的预后一直被认为极其不佳。我们试图在一项回顾性队列研究中重新评估近期的治疗结果及预测因素。在2001年至2006年间接受HSCT的605例成年患者中,有154例需要入住ICU。其中,47%的患者从ICU出院,36%的患者从医院出院,19%的患者存活6个月。异基因移植、机械通气、使用血管升压药和中性粒细胞减少均与死亡率增加相关,具有所有这四个特征的患者死亡率为100%。在Kaplan-Meier分析中,血液透析也与死亡率增加相关,但在多变量树分析中似乎并不重要。最终的Cox模型证实,异基因移植、机械通气和使用血管升压药均是ICU入院后6个月内死亡的独立危险因素。